Post on 04-Jan-2016
description
University of Cincinnati University of Cincinnati
Intellectual Property Office
UC FirstsUC Firsts
First oral polio vaccine – Albert SabinFirst antihistamine, Benadryl –
George Rieveschl First safe anti-knock gasoline First electric organ – Winston KochFirst use of a YAG laser to remove
brain tumor
Mission of Intellectual Property OfficeMission of Intellectual Property Office
Main Mission - Technology Transfer– Assess new invention disclosures– Develop strategies for protecting University’s
IP – Transfer University’s IP to industry for the
public good and commercial gain (increase society’s wealth locally and nationally)
– Promote entrepreneurship through faculty counseling and referral
– Provide University presence within industrial and investment communities
Technology Transfer ProcessTechnology Transfer Process
Process begins with the submission of an invention disclosure
Evaluation involves the investigation of many complex patent/legal, ownership and business related questions. – Esp pre-existing obligations to sponsor
Ongoing Administrative ObligationsOngoing Administrative Obligations
Bayh-Dole Compliance– Reporting– Election of Title– Patent Filing Decisions – Invention Utilization
Licensee Diligence – Progress reports – Milestone, royalty payments
Skills SetSkills Set
Complexity of University Technology Transfer demands sophisticated knowledge of many different fields
– patent law – licensing & contract law – federal, state, and university polices & laws related to IP– in-depth understanding of market trends – capacity to understand new technical developments
We’re fortunate in our office to have a team with a highly complimentary skills set (PhD, JD, MBA)
Intellectual Property StaffIntellectual Property Staff
About Our Office About Our Office
Approx 75 active licenses 164 active patents $6.5 million in license revenue in FY02 Over 50% of US patents issued to us in
the last 5 years have been licensed or optioned to industry
Top 1/3 of Technology Transfer Offices nationwide, top office in tri-state
Invention Disclosures and PatentsInvention Disclosures and Patents
0
1020
30
4050
60
7080
90
100
FY 98 FY 99 FY 00 FY 01 FY 02
InventionDisclosure
Issued US Patents
Licensing Income Licensing Income
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
FY 98 FY 99 FY 00 FY 01 FY 02
License Income(million $)
UC IP Helping to Advance Local FirmsUC IP Helping to Advance Local Firms
Small Firms– KY Pharmaceutical firm
Considering license to slow-release diuretic technology and sponsoring research to develop the product. Also considering re-locating R&D from KY to Bio/Start
– Local Medical Device firm Considering license to early stroke diagnostic technology
and also sponsoring research at UC to develop the medical device
– Local Biosensor firm Interested in acquiring a license to our biosensor
technology and partnering with us on development environment monitoring equipment
UC Helping Cont’d UC Helping Cont’d
Large Firms – P&G Pharmaceuticals
Collaborative research in area of obesity
– Halliburtin Oil drilling technology
– GEAerospace technology
Example Recent License AgreementExample Recent License Agreement
Inventors - Drs. Joseph Clark (UC) and Ton Degrauw (Children’s Hospital) and Rima Daouk (Avicena)
Licensee - Avicena (Biotech in Cambridge, MA) Invention - Discovered that a mutations in gene
that encodes creatine transport protein located on X chromosome (afflicts males) can cause mental retardation
Currently working on a cure License complemented with sponsored research
agreement designed to determine prevalence of this defect and to identify therapeutics
Examples of Faculty Start-upsExamples of Faculty Start-ups
Extreme Photonics (solid-state display) Apologic (develops drugs for Apo-E related
diseases, e.g., Alzheimer’s) CardioEnergetics (mechanical devices for treating
heart failure) Cutanogen (skin substitutes) Allergenics (oral vaccines) Phase 2 Discovery (develops drugs for treating
psychiatric and neurologic disorders) Intracellular (cellular imaging instruments)
Extreme PhotonicsExtreme Photonics
"Extreme" Engineering Innovation Launches High-tech Firm
An idea born in the labs of Ohio Eminent Scholar Andrew Steckl led to the birth of Cincinnati's newest high-tech company -- Extreme Photonix.
The company was started by Steckl, Gieringer Professor of Solid State Microelectronics in the electrical and computer engineering and computer science department. Research Corporation Technologies (RCT) of Tuscon, Ariz., recently announced it would support the company's research and development so prototype products can be made.
Examples of Licensing OpportunitiesExamples of Licensing Opportunities
Pharmacogenomics – Genetic test for asthma and congestive heart patients to
help physician to determine best drug Diagnostic
– Blood test that can diagnosis any neurological disease (stroke, epilepsy, possibly even Alzheimer’s)
Medical Device– Ultrasonic “clot busting” device for treating stroke
Therapeutic – Patented Cystic Fibrosis drug
Ultrasound Enhances tPA ThrombolysisUltrasound Enhances tPA Thrombolysis
QuestionsQuestions
Richard Kordal, Ph.D., Director, IPO
University of Cincinnati
Mail Location 0829
Cincinnati, OH 45267-0829
Ph: (513) 556-4724
Fax: (513) 558-2296
Email: richard.kordal@uc.edu